[144] Axogen, Inc. SEC Filing

Rhea-AI Filing Summary

Axogen, Inc. insider filing shows a proposed sale of 14,937 common shares, with an aggregate market value of $267,073.56, through Morgan Stanley Smith Barney LLC on 10/03/2025. The shares were acquired as Restricted Stock Units on 09/01/2024. The filer declares no undisclosed material information and notes reliance on Rule 144 and any applicable 10b5-1 trading plan mechanics. The notice also reports recent sales on 10/02/2025 totaling 10,020 shares for gross proceeds of $180,424.04 executed under a 10b5-1 program and an irrevocable trust.

Positive

• 14,937 shares identified for sale are explicitly from Restricted Stock Units acquired on 09/01/2024
• Sale to be routed through a major broker: Morgan Stanley Smith Barney LLC, providing execution transparency
• Filer attests to no undisclosed material information and references reliance on Rule 10b5-1 mechanics

Negative

• Insider sold 7,620 and 2,400 shares on 10/02/2025 for combined gross proceeds of $180,424.04, indicating continued insider selling
• Proposed sale of 14,937 shares represents incremental supply in the market on 10/03/2025

Insights

Insider Transactions Analyst

TL;DR: Insider proposes to sell 14,937 shares on 10/03/2025; prior sales of 10,020 shares occurred on 10/02/2025.

The filing discloses a planned sale of 14,937 common shares valued at $267,073.56 via Morgan Stanley Smith Barney LLC. These shares were granted as Restricted Stock Units on 09/01/2024, indicating the transaction relates to vested compensation rather than open-market purchases.

The schedule also records recent 10b5-1 sales and a trust sale totaling 10,020 shares for $180,424.04 on 10/02/2025, showing active disposition of shares over consecutive days. The filer affirms no undisclosed material information under the signature block.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14937	267073.56	46012574	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2024	Restricted Stock Units	Issuer			14937	09/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WILLIAM BURKE 13631 Progress Blvd., Suite 400 Alachua FL 32615	Common	10/02/2025	7620	137200.04
Elizabeth J Burke 2024 Irrevocable Trust 13631 Progress Blvd., Suite 400 Alachua FL 32615	Common	10/02/2025	2400	43224.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Axogen (AXGN) report in this Form 144?

The filing reports a proposed sale of 14,937 common shares valued at $267,073.56, to be sold on 10/03/2025 through Morgan Stanley Smith Barney LLC.

When were the shares being sold by the filer acquired?

The shares were acquired as Restricted Stock Units on 09/01/2024.

Were there any recent insider sales disclosed?

Yes; the filing shows 10b5-1 sales on 10/02/2025 of 7,620 shares for $137,200.04 and a trust sale of 2,400 shares for $43,224.00.

Through which broker will the proposed sale be executed?

The sale is scheduled to be executed through Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filer claim any undisclosed material information?

No. By signing the notice, the person represents they do not know any material adverse information that has not been publicly disclosed.